| Document Date: 2013-05-23 16:35:17
Open Document File Size: 480,10 KBShare Result on Facebook
City Ann Arbor / Mississauga / / Company GlaxoSmithKline Inc. / mCi / Anti-Neoplastic Radioimmunotherapeutic GlaxoSmithKline Inc. / / Event Product Issues / FDA Phase / / IndustryTerm biologic product / mean energy / energy / murine antibody technology / / MedicalCondition allergic reaction / lymphoma / Flu / myelodysplastic syndrome / serious allergic reactions / nausea / secondary leukemia / anaphylaxis / thrombocytopenia / severe hypersensitivity / premature menopause / Immune Hypersensitivity Reactions Including Anaphylaxis / miscarriage / hypogonadism / hypersensitivity / infections / sepsis / hypotension / severe allergic reactions / nonHodgkin's lymphoma / leukemia / non-Hodgkin's lymphoma / pneumonia / Secondary Leukemias / bronchospasm / acute leukemia / IV disease / dyspnea / hypothyroidism / chills / Carcinogenesis / neutropenia / fever / Serious hypersensitivity / severe thrombocytopenia / myelodysplasia / pleural effusion / angioedema / allergic reactions / Metabolism Hypothyroidism / rigors / anemia / azoospermia / lymphoma marrow involvement / dehydration / / MedicalTreatment Immunization / chemotherapy / radioimmunotherapy / RADIATION / contraceptive methods / / Movie Half-Life / / Organization Administration of BEXXAR / DOSAGE AND ADMINISTRATION / / Position investigator / driver / / Product BEXXAR / epinephrine / 6L4 / be obtained weekly following BEXXAR / bone marrow reserve / renal function / / ProvinceOrState Ontario / / SportsEvent NHL / Lead Shielding Shield / / Technology RADIATION / diagnostic tests / antibodies / radiopharmaceuticals / transplantation / Geriatrics / chemotherapy / murine antibody technology / /
SocialTag |
Microsoft Word - Bexxar_PM _2013-04-19_.doc